Loading organizations...
§ Private Profile · Redwood City, CA, USA
medical device company developing water vapor technology for women's healthcare, focused on menorrhagia treatment.
Based in Menlo Park, California, AEGEA Medical is a medical device company that develops the Mara Water Vapor Ablation System to treat heavy menstrual bleeding. The organization provides an in-office alternative to traditional surgical procedures by utilizing controlled, low-pressure natural water vapor to ablate the uterine lining. Prior to its acquisition, the enterprise secured $115.17 million in total venture capital funding, which included a $40 million Series D financing round in 2018 to commercialize its FDA-approved medical technology. The company received financial backing from notable venture capital firms, including Solas BioVentures, Alloy Ventures, and Delphi Ventures. In February 2021, the business was officially acquired by CooperSurgical to integrate the water vapor treatment system into its broader women's healthcare portfolio. AEGEA Medical was originally founded in 2007 by an undisclosed group of medical technology entrepreneurs.
AEGEA Medical has raised $106.3M across 4 funding rounds.
AEGEA Medical has raised $106.3M in total across 4 funding rounds.
AEGEA Medical has raised $106.3M across 4 funding rounds. Most recently, it raised $17.0M Other Equity in November 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 12, 2018 | $17M Venture Round | AT FX | — | Announced |
| Jan 2, 2018 | $40M Venture Round | SAM Chawla | Alloy Ventures, Biomed Ventures, Delphi Ventures, Medtronic, Solas BioVentures | Announced |
| May 4, 2015 | $36M Series C | — | Alloy Ventures, Biomed Ventures, Covidien, Delphi Ventures, Solas BioVentures | Announced |
| Jun 30, 2011 | $13.3M Venture Round | AMY Belt Raimundo | Douglas Kelly, MD, Delphi Ventures | Announced |
AEGEA Medical has raised $106.3M in total across 4 funding rounds.
AEGEA Medical's investors include AT FX, Sam Chawla, Alloy Ventures, BioMed Ventures, Delphi Ventures, Medtronic, Solas BioVentures, Covidien, Amy Belt Raimundo, Douglas Kelly, MD.